-
Bay 11-7085: Translational NF-κB Strategy
2026-08-25
Bay 11-7085 offers translational researchers a practical way to interrogate NF-κB-dependent inflammation, proliferation, and apoptosis. This thought-leadership guide connects its mechanism to endometriosis, pneumococcal meningitis, and ER stress-related neuroinflammation after subarachnoid hemorrhage while emphasizing controls, model maturity, and the limits of chemical-probe evidence.
-
MG-132: From Proteostasis to Translational Insight
2026-08-25
A mechanistic and strategic guide to using MG-132 (Z-LLL-al) to connect proteasome inhibition with apoptosis, cell-cycle control, oxidative stress, and translational research decisions.
-
Tropifexor (LJN452): A Translational FXR Playbook
2026-08-24
Tropifexor (LJN452) offers a precise way to interrogate FXR biology across intestinal barrier, metabolic, and liver disease models. This thought-leadership guide connects receptor pharmacology with experimental design, translational decision-making, and evidence-based pathway attribution.
-
Deferasirox Fe3+ Chelate: Assay Design Guide
2026-08-24
Deferasirox Fe3+ chelate supports iron overload treatment research with a key experimental distinction: a preformed ferric complex is not automatically equivalent to free deferasirox. This guide connects iron chelation mechanism, assay selection, speciation, and reproducible handling for beta-thalassemia and chronic anemia research.
-
A Multimodal iPSC Platform for Cystic Fibrosis Drugs
2026-08-23
Berical and colleagues developed patient-derived iPSC airway models representing common and rare CFTR dysfunction and adapted complementary functional assays for drug testing. The platform links genotype to baseline channel activity and modulator response, offering a route to investigate CFTR variants that are difficult to study with conventional models.
-
Deferasirox, ROS, and NF-κB in Myeloid Maturation
2026-08-22
Jeffries and colleagues show that deferasirox affects myeloid maturation in a stage-dependent manner, linking mitochondrial ROS, NF-κB-related transcription, and reduced terminal neutrophil maturation. The work clarifies why an oral iron chelator can produce distinct effects in progenitors and mature neutrophils while highlighting oxygen tension as an important experimental variable.
-
Hematoxylin and Eosin Staining Kit Guide
2026-08-22
The Hematoxylin and Eosin Staining Kit provides ready-to-use reagents for consistent nuclear and cytoplasmic contrast in paraffin sections, frozen sections, and cytological preparations. It is intended for research-based tissue morphology visualization and cellular structure assessment, not clinical diagnosis or medical use.
-
Cepharanthine: From Mechanism to Translation
2026-08-21
Cepharanthine, a biscoclaurine alkaloid, is emerging as a versatile translational research tool linking mitochondrial apoptosis, DNA-damage signaling, immunomodulation, and disease modeling. This thought-leadership analysis examines recent endometriosis evidence, cancer applications, experimental design, competitive positioning, and the practical steps needed to move from cell assays to patient-derived organoids and in vivo validation.
-
MDockPeP2_VS for Peptide Inhibitor Discovery
2026-08-20
The 2024 PNAS Nexus study introduces MDockPeP2_VS, an automated structure-based method that narrows peptide conformational searches by combining molecular docking with structural conservation between protein folding and protein–peptide binding. Applied to TEM-1 β-lactamase, the workflow identified TF7 as a micromolar inhibitor, illustrating how computational peptide screening can support β-lactam antibiotic resistance research.
-
EPI-001: A Domain-Aware AR Assay Strategy
2026-08-20
EPI-001, an androgen receptor N-terminal domain inhibitor, offers a way to distinguish ligand-binding-domain escape from broader AR transcriptional control. This article translates prostate and triple-negative breast cancer evidence into a practical, mechanism-led assay strategy.
-
circEIF2S2 Drives Colorectal Cancer Progression
2026-08-19
The reference study identifies an EIF4A3–circEIF2S2–miR-646–UHMK1 regulatory axis that connects circular RNA biogenesis with colorectal cancer growth, metastasis, and immune suppression. Its combined molecular, cellular, co-culture, and xenograft evidence positions circEIF2S2 as a mechanistically testable candidate for CRC biology, while also highlighting the need for further validation in clinically representative models.
-
SW033291: 15-PGDH Inhibitor Workflows
2026-08-19
SW033291 is a potent 15-PGDH inhibitor for connecting prostaglandin E2 elevation with hematopoiesis, stem-cell behavior, and tissue repair. This practical guide explains compound handling, enzyme and cell assays, combination studies, and troubleshooting for reproducible regeneration research.
-
Gamithromycin Against MmmSC: In Vitro Pharmacodynamics
2026-08-18
Mitchell and colleagues established a matrix-aware in vitro pharmacodynamic framework for comparing gamithromycin with tylosin and tilmicosin against Mycoplasma mycoides subspecies mycoides Small Colony. The study showed substantially lower apparent MICs in adult bovine serum, while time-kill and post-antibiotic-effect data indicated predominantly static activity and class-dependent persistence.
-
AR Heterogeneity and Enzalutamide Response in Prostate Cance
2026-08-18
The reference study shows that androgen receptor heterogeneity is functionally important in castration-resistant prostate cancer, not merely a descriptive feature. By integrating patient tissues, engineered LNCaP models, xenografts, RNA sequencing, and combination therapy experiments, it connects AR state with enzalutamide response and identifies BCL-2 as a candidate vulnerability.
-
Tropisetron Hydrochloride Assay Workflows
2026-08-17
Tropisetron Hydrochloride enables paired studies of 5-HT3 receptor signaling, α7-nicotinic receptor activity, and renal organic-cation transport. This workflow-focused guide shows how to separate receptor pharmacology from OCT2/MATE1 effects, choose complementary assay formats, and troubleshoot concentration, solubility, and transporter-specific artifacts.